​

Eterna Therapeutics Ownership | Who Owns Eterna Therapeutics?

OverviewRevenueFinancialsChart

Eterna Therapeutics Ownership Summary

Eterna Therapeutics is owned by 2.79% institutional investors, 73.98% insiders, and 23.23% retail investors. Fidelity Extended Market Index is the top mutual fund, with 0.32% of its assets in Eterna Therapeutics shares.

ERNA Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockEterna Therapeutics2.79%73.98%23.23%
SectorHealthcare Stocks 278.45%10.60%-189.04%
IndustryBiotech Stocks 63.84%10.66%25.50%

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 2025268.33%1,488,38549.68%25.25%129.09%525.00%
Dec 31, 20242420.00%994,39339.80%74.22%11120.00%433.33%
Sep 30, 2024205.26%711,29982.35%1325.29%5-3200.00%
Jun 30, 202419-13.64%390,079-4.67%712.60%5-28.57%1-
Mar 31, 20242215.79%409,206-53.29%72.78%775.00%1-80.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Extended Market Index196.92K0.32%-1.88K
Fidelity Series Total Market Index47.90K0.08%-
Spartan Extended Market Index Pool F45.59K0.07%1.88K
Vanguard Institutional Extnd Mkt Idx Tr32.21K0.05%-
BlackRock Extended Equity Market K2.28K0.04%-1.00
Fidelity Nasdaq Composite Index1.17K0.02%-
Vanguard Total Stock Mkt Idx Inv12.09K0.02%-
Spartan Total Market Index Pool G9.13K0.01%8.49K
SSgA U.S. Extended Market Index Class I766.000.01%-
Extended Equity Market Fund M290.000.01%-1.00

Recent Insider Transactions

DateNameRoleActivityValue
Jun 09, 2025Cherington Charles-Buy$2.22M
Sep 24, 2024Cherington Charles-Buy-
Sep 24, 2024Cherington Charles-Buy$1.77M
Sep 24, 2024Cherington Charles-Buy$2.24M
Sep 24, 2024Cherington Charles-Buy-

Insider Transactions Trends

DateBuySell
2025 Q22-
2025 Q1--
2024 Q473
2024 Q34-
2024 Q2--

ERNA Ownership FAQ

Who Owns Eterna Therapeutics?

Eterna Therapeutics shareholders are primarily institutional investors at 2.79%, followed by 73.98% insiders and 23.23% retail investors. The average institutional ownership in Eterna Therapeutics's industry, Biotech Stocks , is 63.84%, which Eterna Therapeutics falls below.

Does Blackrock own Eterna Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Eterna Therapeutics.

Who is the top mutual fund holder of Eterna Therapeutics shares?

Fidelity Extended Market Index is the top mutual fund holder of Eterna Therapeutics shares, with 0.32% of its total shares outstanding invested in 196.92K Eterna Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools